"countermeasures for viral pathogens. This is a transfer from the department of interior agreement no.: D18AC00002 amend. 0010. That document does not exists in fpds-NG.
Other Transaction IDV Awarded Last action
- Contract number
- HR00112190034
- Awardee
-
Abcellera Biologics Inc. UEI D3LSBFZ6MXE3
- Awarding agency
-
Defense Contract Management Agency
Department of Defense
- Task orders
- 0
Award facts
- Last date to order
- Not on record
- IDV ceiling
- $54,863,580.00
- Contracting staff
- Funding agency
- Defense Advanced Research Projects Agency Department of Defense
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Competed Broad Agency Announcement
- Pricing
- Other
Award details come from SAM.gov/FPDS.
About this IDV
This Other Transaction (OT) Indefinite Delivery Vehicle (IDV) was awarded by the Defense Advanced Research Projects Agency (DARPA), a defense agency, to Abcellera Biologics Inc. The $54,863,580.00 contract is for countermeasures against viral pathogens, which was transferred from an earlier Department of Interior agreement. The IDV does not include any set-asides and was awarded on December 1, 2020, with a period of performance that is not specified. The contracted products and services appear to involve the development of viral countermeasures, though the specific details of the requirements and task orders are not provided. As an OT agreement, this contract utilizes an alternative contracting mechanism outside the standard Federal Acquisition Regulation (FAR) framework, affording DARPA greater flexibility in procuring innovative solutions to address emerging threats.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $17,624,973 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | -$1,641,467 | |
| Funding Only Action | $1,459,756 | |
| Funding Only Action | $8,659,203 | |
| Funding Only Action | $3,004,930 | |
| Funding Only Action | $5,921,587 | |
| Funding Only Action | $5,650,853 | |
| Funding Only Action | $4,066,554 | |
| Original award | $0 |
Show all 17
Quick answers
Who was awarded contract HR00112190034?
HR00112190034 was awarded to Abcellera Biologics Inc. by Defense Contract Management Agency (Department of Defense) on December 1, 2020.
How much is contract HR00112190034 worth?
HR00112190034's own ceiling is $54,863,580.
Which agency awarded contract HR00112190034?
Defense Contract Management Agency (Department of Defense) awarded HR00112190034, with funding from Defense Advanced Research Projects Agency (Department of Defense).
Was contract HR00112190034 competed?
The extent of competition for HR00112190034 was competed.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV